Fabrice Egros

Insider Reports History

Entity
Individual
Location
C/O Syndax Pharmaceuticals, Inc., Totten Pond Road, Suite 140, Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fabrice Egros:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 32K $584K $18.27 Feb 2, 2022 Direct

Insider Reports Filed by Fabrice Egros

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $0 4 Feb 3, 2022 Director
SNDX Syndax Pharmaceuticals Inc Nov 18, 2021 6 -$128K 4 Nov 19, 2021 Director
SNDX Syndax Pharmaceuticals Inc Aug 18, 2021 3 -$123K 4 Aug 20, 2021 Director
SNDX Syndax Pharmaceuticals Inc May 18, 2021 6 -$155K 4 May 20, 2021 Director